share_log

Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer VARKI PAUL

Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer VARKI PAUL

Avalo Therapeutics | 4:持股變動聲明-高管 VARKI PAUL
美股sec公告 ·  06/25 16:12
Moomoo AI 已提取核心訊息
Paul Varki, the Chief Legal Officer of Avalo Therapeutics, Inc., was involved in a transaction with the company's stock on June 24, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Following the action, the updated number of shares held by Varki was also not provided. This information is crucial for investors to understand the insider activity within Avalo Therapeutics and may influence their investment decisions.
Paul Varki, the Chief Legal Officer of Avalo Therapeutics, Inc., was involved in a transaction with the company's stock on June 24, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Following the action, the updated number of shares held by Varki was also not provided. This information is crucial for investors to understand the insider activity within Avalo Therapeutics and may influence their investment decisions.
2024年6月24日,Avalo Therapeutics公司的首席法律官Paul Varki參與了一項交易。公告未披露交易的具體細節,包括交易的股票數、股票性質、交易價格以及股票總價值。在此次交易後,Varki持有的股票數量也沒有提供更新。這些信息對投資者了解Avalo Therapeutics內部活動至關重要,可能會影響他們的投資決策。
2024年6月24日,Avalo Therapeutics公司的首席法律官Paul Varki參與了一項交易。公告未披露交易的具體細節,包括交易的股票數、股票性質、交易價格以及股票總價值。在此次交易後,Varki持有的股票數量也沒有提供更新。這些信息對投資者了解Avalo Therapeutics內部活動至關重要,可能會影響他們的投資決策。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息